Sotac Pharmaceuticals Peer Comparison

NSE: SOTAC

₹90.05

₹0.00 (0.00%)

As on 27-Aug-2026 11:34IST

Market cap

₹100 Cr

Revenue (TTM)

₹97 Cr

P/E Ratio

17.3

P/B Ratio

1.8

Div. Yield

0.2 %

Edit

	Sotac Pharmaceuticals	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Market cap (₹ Cr)	100	30,609	29,986	28,284	27,186
Revenue (₹ Cr)	97	3,564	1,936	9,205	1,462
Net Profit (₹ Cr)	9.28	414.00	288.22	-371.81	387.35
Net Margin (%)	9.19	11.23	14.79	-3.93	26.01
RoE (%)	18.83	8.38	29.77	-3.85	25.18
Price to Earnings	17.25	74.84	104.04	--	70.39
Price-To-Book	1.79	6.08	22.34	3.53	15.73

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Sotac Pharmaceuticals	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Operating Revenue	96.99	3,012.00	1,284.27	9,151.18	1,006.88
Total Income	100.88	3,074.00	1,296.22	9,312.95	1,023.80
Total Expenditure	83.35	2,619.00	1,028.33	7,733.31	774.80
EBITDA	13.64	393.00	255.95	1,417.87	232.07
Depreciation	3.84	217.00	36.59	816.34	26.62
EBIT	9.80	176.00	219.36	601.53	205.45
Interest	2.58	254.00	36.78	421.59	6.22
Other Income	3.90	62.00	11.95	161.77	16.93
Exceptional Items	--	--	--	--	--
Profit before Tax	11.12	-16.00	194.52	414.64	216.16
Provision for Tax	1.84	41.00	60.16	323.51	55.75
Profit after Tax	9.28	-57.00	134.36	91.13	160.42

Liabilities (₹ Cr)

	Sotac Pharmaceuticals	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Shareholder's Funds	53.25	4,353.00	540.98	8,125.47	1,309.63
Minority Interest	5.17	304.00	0.00	--	10.45
Non-Current Liabilities	13.06	887.00	122.65	3,392.72	26.93
Current Liabilities	51.55	2,042.00	786.03	3,850.56	202.25
Total Liabilities	124.33	8,100.00	1,451.43	15,513.53	1,549.26

Assets (₹ Cr)

	Sotac Pharmaceuticals	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Non-Current Assets	53.20	5,017.00	386.29	9,487.47	757.63
Current Assets	69.83	2,465.00	1,063.37	5,881.28	791.64
Total Assets	124.33	8,100.00	1,451.43	15,513.53	1,549.26
Total Debt*	43.70	1,859.00	393.17	4,720.27	8.18
Net Current Assets	18.28	423.00	277.34	2,030.72	589.39
Contingent Liabilities	1.53	770.26	12.25	99.76	15.38

Cashflow (₹ Cr)

	Sotac Pharmaceuticals	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Cash From Operating Activities	-4.33	-22.00	159.18	892.30	118.34
Cash Flow from Investing Activities	-13.62	-783.00	-64.81	-477.46	-223.94
Cash from Financing Activities	16.09	409.00	-39.81	-440.83	261.12
Net Cash Inflow / Outflow	-1.85	-396.00	54.56	-25.99	155.52

Ratios

Profitability Ratios

	Sotac Pharmaceuticals	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
ROCE (%)	16.40	4.07	26.97	6.61	20.14
ROE (%)	18.83	-1.48	30.68	1.14	16.19
ROA (%)	8.17	-0.78	10.50	0.60	12.13
EBIT Margin (%)	18.08	15.11	20.86	17.26	24.73
Net Margin (%)	9.19	-1.85	10.37	0.98	15.67
Cash Profit Margin (%)	13.52	4.14	7.13	8.54	18.58

Growth Ratios

	Sotac Pharmaceuticals	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Revenue Growth (%)	-6.59	7.65	50.40	11.99	40.34
EBIT Growth (%)	99.21	272.95	54.77	15.16	83.12
Net Profit Growth (%)	159.14	87.92	47.63	411.39	229.35
EPS Growth (%)	87.48	90.35	45.69	410.84	67.16
Book Value Growth (%)	17.66	29.77	42.49	2.28	94.96

Valuation Ratios

	Sotac Pharmaceuticals	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Price / Earnings	16.35	0.00	0.00	326.26	62.97
Price / Book Value	2.46	5.31	0.00	3.69	15.26
Dividend Yield (%)	0.08	0.00	--	0.06	0.06
EV/EBITDA	9.89	54.36	1.09	21.49	79.31
Market Cap (₹ Cr)	131.22	23,064.69	0.00	29,731.27	19,988.69

Solvency Ratios

	Sotac Pharmaceuticals	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Debt to Equity	0.82	0.43	0.76	0.59	0.01
Short term debt to equity ratio	0.35	0.11	0.54	0.12	0.01
Current Ratio	1.35	1.21	1.35	1.53	3.91
Quick Ratio	0.96	0.85	0.69	0.93	3.02
Interest Coverage	5.31	0.94	6.29	1.98	35.76

Operating Efficiency Ratios

	Sotac Pharmaceuticals	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Debtors to sales (%)	35.17	21.95	25.21	25.67	28.85
Asset Turnover	0.85	0.53	1.87	0.70	0.76
Receivable days	113.65	60.36	47.59	77.05	90.06
Inventory Days	72.01	64.42	62.58	77.13	61.02
Payable days	127.81	218.94	228.78	173.49	96.06
Cash Conversion Cycle	57.86	-94.15	-118.62	-19.30	55.02